Merck & Co., Inc. is 216.1x more valuable than ATAI Life Sciences N.V. by market capitalization ($298.26 B vs $1.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATAI | MRK |
|---|---|---|
| Market cap | $1.38 B | $298.26 B |
| US-listed rank | #2408 | #45 |
| Revenue (latest FY) | $308.00K | $65.01B |
| Net income (latest FY) | -$149.27M | $18.25B |
| Net margin | -48464.0% | 28.1% |
| P/E (trailing FY) | - | 16.3 |
| SEC filings | 320 | 996 |
Merck & Co., Inc. is 216.1x more valuable than ATAI Life Sciences N.V. by market capitalization ($298.26 B vs $1.38 B).
In their latest fiscal years, ATAI Life Sciences N.V. reported $308.00K in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: ATAI Life Sciences N.V. and Merck & Co., Inc., or browse the full rankings.